Molbio Diagnostics IPO debut Monday: GMP signals near 20% pop

Molbio Diagnostics is a company in India that makes quick medical tests to find diseases.

The company needed money to grow, so it sold parts of itself to investors in a process called an IPO.

Many people wanted to buy in, so the sale was 70 times more popular than expected.

Each share was priced at ₹807.

Before the shares officially start trading, some people guess their price in an unofficial 'grey market.'

On Friday, the grey market suggested each share could sell for about ₹963.

That means buyers expect the share price to jump by about 19 percent on its first day.

The shares will begin trading on Monday, 17 August, on India's two big stock exchanges.

The money raised will go toward research labs, new equipment, and offices.

Share prices can go up or down, so investing means taking some risk.